Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report
A 47-year-old non-smoker male who has received the first dose of the BNT162b2 mRNA Covid-19 vaccine in Saudi Arabia. At day 3 post-vaccination, he tested negative for Covid-19 and travelled to Egypt. On day 12 he developed runny nose, body ache and fever, and he reportedly tested (PCR) negative for...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Journal of Infection and Public Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034121001933 |
id |
doaj-e9b890cd8c404bd596382b5556c109b2 |
---|---|
record_format |
Article |
spelling |
doaj-e9b890cd8c404bd596382b5556c109b22021-07-31T04:38:12ZengElsevierJournal of Infection and Public Health1876-03412021-08-0114811231125Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case reportAsem A. Allam0Anwar A. Sayed1Department of Internal Medicine and Critical Care, King Abdullah Bin Abdul-Aziz University Hospital, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi ArabiaDepartment of Medical Microbiology and Immunology, Taibah University, Madinah, Saudi Arabia; Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Corresponding author at: Department of Medical Microbiology and Immunology, Faculty of Medicine, Taibah University, Madinah, 42353, Saudi Arabia.A 47-year-old non-smoker male who has received the first dose of the BNT162b2 mRNA Covid-19 vaccine in Saudi Arabia. At day 3 post-vaccination, he tested negative for Covid-19 and travelled to Egypt. On day 12 he developed runny nose, body ache and fever, and he reportedly tested (PCR) negative for Covid-19 Upon his return to Saudi on day 15, his symptoms have worsened and he presented to the Emergency Department, at which he tested positive for Covid-19. The patient was overweight (BMI = 29), was not suffering from any comorbidities and was not taking any medication. Upon examination, he was vitally stable and his laboratory investigation only revealed a slightly increased Creatinine. His chest X-ray was unremarkable.His condition did not require hospital admission, so he was discharged and advised to home-isolate himself. Four days after his discharge, his entire household came to the hospital and tested positive for Covid-19.This is the first case report, in Saudi Arabia, of a person receiving the first dose of the BNT162b2 vaccine and got infected with Covid-19 afterwards. The report highlights the significance of receiving the second dose of the vaccine to be effective. It also demonstrates that those with a single dose mRNA vaccine, could get infected and transmit the infection.http://www.sciencedirect.com/science/article/pii/S1876034121001933COVID-19Vaccine efficacySaudi ArabiaPost-vaccination infectionSARS-CoV-2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Asem A. Allam Anwar A. Sayed |
spellingShingle |
Asem A. Allam Anwar A. Sayed Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report Journal of Infection and Public Health COVID-19 Vaccine efficacy Saudi Arabia Post-vaccination infection SARS-CoV-2 |
author_facet |
Asem A. Allam Anwar A. Sayed |
author_sort |
Asem A. Allam |
title |
Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report |
title_short |
Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report |
title_full |
Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report |
title_fullStr |
Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report |
title_full_unstemmed |
Active Covid-19 infection and transmission after the first dose of the BNT162b2 mRNA vaccination in Saudi Arabia: A case report |
title_sort |
active covid-19 infection and transmission after the first dose of the bnt162b2 mrna vaccination in saudi arabia: a case report |
publisher |
Elsevier |
series |
Journal of Infection and Public Health |
issn |
1876-0341 |
publishDate |
2021-08-01 |
description |
A 47-year-old non-smoker male who has received the first dose of the BNT162b2 mRNA Covid-19 vaccine in Saudi Arabia. At day 3 post-vaccination, he tested negative for Covid-19 and travelled to Egypt. On day 12 he developed runny nose, body ache and fever, and he reportedly tested (PCR) negative for Covid-19 Upon his return to Saudi on day 15, his symptoms have worsened and he presented to the Emergency Department, at which he tested positive for Covid-19. The patient was overweight (BMI = 29), was not suffering from any comorbidities and was not taking any medication. Upon examination, he was vitally stable and his laboratory investigation only revealed a slightly increased Creatinine. His chest X-ray was unremarkable.His condition did not require hospital admission, so he was discharged and advised to home-isolate himself. Four days after his discharge, his entire household came to the hospital and tested positive for Covid-19.This is the first case report, in Saudi Arabia, of a person receiving the first dose of the BNT162b2 vaccine and got infected with Covid-19 afterwards. The report highlights the significance of receiving the second dose of the vaccine to be effective. It also demonstrates that those with a single dose mRNA vaccine, could get infected and transmit the infection. |
topic |
COVID-19 Vaccine efficacy Saudi Arabia Post-vaccination infection SARS-CoV-2 |
url |
http://www.sciencedirect.com/science/article/pii/S1876034121001933 |
work_keys_str_mv |
AT asemaallam activecovid19infectionandtransmissionafterthefirstdoseofthebnt162b2mrnavaccinationinsaudiarabiaacasereport AT anwarasayed activecovid19infectionandtransmissionafterthefirstdoseofthebnt162b2mrnavaccinationinsaudiarabiaacasereport |
_version_ |
1721247193740869632 |